NASDAQ$NOVT

Novanta Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Novanta demonstrated strong double-digit growth in sales, bookings, and profit.

Novanta reported a revenue of $199.0 million for Q4 2021, a 34.9% increase compared to Q4 2020. Customer demand continued to be robust in advanced industrial and medical applications, and customer orders were up 92% year over year.

  • GAAP revenue of $199.0 million, an increase of 34.9% versus Q4 2020.
  • Acquisition activities resulted in an increase in revenue of $32.1 million, or 21.8%, compared to Q4 2020.
  • GAAP operating income was $21.7 million, compared to $17.1 million in Q4 2020.
  • Adjusted EBITDA was $42.6 million, compared to $32.4 million in Q4 2020.

Headline financials

Total Revenue

$199M

Previous: $147M+34.9%
EPS (adj)

$0.67

Previous: $0.53+26.4%
Adjusted EBITDA

$42.6M

Previous: $32.4M+31.5%
Capital Expenditures

$5.22M

Previous: $3.36M+55.3%
Free Cash Flow

$23.5M

Previous: $43.2M-45.6%
Net Income

$13.8M

Previous: $12.7M+8.7%
Operating Income

$21.7M

Previous: $17.1M+26.9%
Gross Profit

$82.9M

Previous: $62.3M+33.1%
Cash & Equivalents

$117M

Previous: $125M-6.1%
Total Assets

$1.23B

Previous: $865M+41.9%
Stock-Based Comp

$5.44M

Previous: $7.05M-22.8%

Revenue & EPS history

Novanta · Revenue · Quarterly

$199M

Q4 2021+34.9%vs Q4 2020
Beat estimate in 16 of 16 quarters(100%)
ActualEstimate

Revenue by segment

Novanta · $83.4M total across 1 segment · Q3 2023

  • Medical Solutions
    $83.4M

Forward guidance

For the first quarter of 2022, the Company expects GAAP revenue to be in the range of approximately $192 million to $200 million. The Company expects Adjusted Gross Profit Margin to be approximately 44.5%. The Company expects Adjusted EBITDA to be in the range of $38 million to $41 million and Adjusted Diluted EPS to be in the range of $0.60 to $0.66.

Tailwinds

  • GAAP revenue to be in the range of approximately $192 million to $200 million.
  • Adjusted Gross Profit Margin to be approximately 44.5%.
  • Adjusted EBITDA to be in the range of $38 million to $41 million
  • Adjusted Diluted EPS to be in the range of $0.60 to $0.66.
  • GAAP revenue to be in the range of approximately $825 million to $845 million for full year 2022.

Headwinds

  • We are experiencing near-term raw material shortages and disruptions
  • cost inflation in our supply chain
  • The Company’s guidance assumes no significant changes in foreign exchange rates.
  • Adjusted EBITDA to be in the range of $172 million to $182 million for full year 2022.
  • Adjusted Diluted EPS to be in the range of $2.85 to $3.00 for full year 2022.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+2.3%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+2.4%

Avg return

30 days after

64%

41 / 64 earnings

Positive

+22.9%

Q3 2018

Best reaction

-11.3%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.2%+10.5%
Q4 2025-2.2%-7.9%-19.4%
Q3 2025+8.4%-17.0%-10.0%
Q1 2025-1.7%+2.4%+5.3%
Q4 2024+7.2%+4.6%-4.2%
Q3 2024+4.5%+4.9%-4.5%
Q2 2024+7.6%+9.4%+10.3%
Q1 2024-1.6%+0.1%+0.8%
Q4 2023+9.9%+12.1%+11.1%
Q3 2023-11.0%-11.0%+9.4%
Q2 2023-11.3%-11.2%-6.9%
Q1 2023+2.2%+0.5%+4.8%
Q4 2022-6.1%-3.7%+1.4%
Q3 2022-3.5%+10.5%+7.2%
Q2 2022-0.4%-0.5%-13.6%
Q1 2022+3.1%+9.5%+3.9%
Q4 2021-1.0%-2.0%+4.1%
Q3 2021-7.4%-8.2%-5.7%
Q2 2021+5.1%+3.8%+8.9%
Q1 2021+2.5%+7.0%+8.1%
Q4 2020-1.3%-4.1%-0.3%
Q3 2020-2.3%-7.5%-2.3%
Q2 2020+4.8%+3.4%-6.1%
Q1 2020+6.6%+3.8%+14.2%
Q4 2019+5.6%+8.4%-10.0%
Q3 2019-5.9%-8.3%-0.1%
Q2 2019-5.3%-8.4%+2.0%
Q1 2019-5.8%-5.3%-6.9%
Q4 2018+4.7%+4.6%+8.6%
Q3 2018+22.9%+21.7%-1.9%
Q2 2018-0.6%+1.9%+13.2%
Q1 2018+2.8%+3.9%+8.1%
Q4 2017+2.8%+0.9%-4.1%
Q3 2017+10.1%+10.1%-1.5%
Q2 2017-0.8%+1.9%+4.0%
Q1 2017+8.6%+12.0%+34.0%
Q4 2016+0.2%+3.9%+5.5%
Q3 2016-1.2%+1.5%+16.9%
Q2 2016+1.7%+2.9%+7.9%
Q1 2016-0.6%
Q4 2015+2.1%
Q3 2015+2.7%
Q2 2015+1.1%
Q1 2015+0.2%
Q4 2014+1.1%
Q3 2014+0.7%
Q2 2014+4.1%
Q1 2014+1.3%
Q4 2013+2.3%
Q3 2013+9.9%
Q2 2013-4.1%
Q1 2013+0.2%
Q4 2009-1.5%
Q4 2012-1.5%
Q3 2012+0.4%
Q2 2012-8.6%
Q1 2011+10.8%
Q1 2012+2.6%
Q4 2011+0.3%
Q3 2010+6.0%
Q3 2011+6.0%
Q4 2010+18.8%
Q2 2011+18.8%
Q2 2010+18.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro